Meta: In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic ...

CURE spoke with experts about radical cystectomy, or surgical removal of the bladder, for patients with bladder cancer.

The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue ...

For patients with lung cancer, advancements such as robotic surgery and video-assisted thoracic surgery have dramatically ...

Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, ...

Robotic and video-assisted thoracic surgery reduces recovery time for those with lung cancer, allowing some to leave the hospital the day after surgery.

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or ...

Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood ...

A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life ...

For patients with bladder cancer undergoing radical cystectomy, or the surgical removal of the bladder, one possible option ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...